BridgeMD
New treatment option for In-Stent Carotid Artery Restenosis
Official title Carotid Endarterectomy vs. Repeated Carotid Angioplasty and Stenting for In-Stent Restenosis
ClinicalTrials.gov ID: NCT05390983
What this study is testing
- What it's testing
- Patients with in-stent restenosis in carotid artery indicated to carotid intervention will be randomized into repeated carotid percutaneous transluminal angioplasty with or without stenting or carotid endarterectomy with stent removal. The objective of the randomized study is to compare the safety and effectiveness of CEA and CAS in patients with in-stent restenosis of the ICA.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- In-stent restenosis in carotid artery 70 - 99 %
- Indication to carotid intervention
- Age 18-80 years
- Functionally independent with a modified Rankin score value of 0 - 2 points
- Signed Informed consent
You likely can't join if
- Contraindication to general anesthesia
- Contraindication to angiography (iodine allergy, etc.)
- Technically impossible to perform angioplasty with or without stenting
- Participation in other clinical study within 60 days
- Technically impossible to perform carotid endarterectomy
The study team makes the final eligibility decision.
Where it's taking place
- Ostrava, Moravian-Silesian Region, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ostrava, Moravian-Silesian Region, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.